Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Cash | 9.10 | 6.12 | 4.28 | 2.83 |
Cash Equivalents | 4.20 | 1.49 | 1.11 | 1.02 |
Short Term Investments | 7.77 | 1.47 | 2.06 | 1.80 |
Cashand Short Term Investments | 21.06 | 9.08 | 7.45 | 5.65 |
Accounts Receivable- Trade Net | 99.62 | 93.98 | 75.31 | 67.20 |
Total Receivables Net | 101.11 | 95.08 | 77.78 | 69.28 |
Total Inventory | 87.81 | 98.01 | 74.40 | 60.39 |
Other Current Assets Total | 25.03 | 25.99 | 24.94 | 28.83 |
Total Current Assets | 235.01 | 228.16 | 184.57 | 164.15 |
Property/ Plant/ Equipment Total- Net | 62.08 | 62.18 | 57.19 | 57.51 |
Goodwill Net | 3.83 | 3.83 | 3.83 | 3.83 |
Intangibles Net | 11.38 | 10.46 | 7.99 | 7.25 |
Long Term Investments | 2.67 | 3.50 | 1.95 | 2.49 |
Note Receivable- Long Term | 0.12 | 0.10 | 0.55 | 0.53 |
Other Long Term Assets Total | 5.31 | 4.95 | 4.45 | 4.33 |
Total Assets | 320.39 | 313.17 | 260.53 | 240.08 |
Accounts Payable | 78.33 | 78.92 | 65.56 | 47.17 |
Current Portof LT Debt/ Capital Leases | 103.27 | 7.76 | 5.88 | 5.27 |
Other Currentliabilities Total | 22.31 | 29.94 | 23.45 | 19.28 |
Total Current Liabilities | 203.91 | 209.33 | 165.64 | 152.53 |
Long Term Debt | 36.38 | 29.97 | 26.85 | 27.28 |
Total Long Term Debt | 36.38 | 30.52 | 27.01 | 27.50 |
Total Debt | 139.65 | 131.00 | 103.64 | 113.59 |
Deferred Income Tax | 3.96 | 2.87 | 0.60 | 2.63 |
Minority Interest | -0.03 | -0.09 | -0.13 | -0.23 |
Other Liabilities Total | 6.88 | 6.74 | 8.78 | 4.07 |
Total Liabilities | 251.09 | 249.38 | 201.91 | 186.50 |
Common Stock Total | 15.80 | 15.69 | 14.82 | 14.82 |
Retained Earnings( Accumulated Deficit) | 53.49 | 48.10 | 43.80 | 38.76 |
Total Equity | 69.29 | 63.79 | 58.63 | 53.58 |
Total Liabilities Shareholders' Equity | 320.39 | 313.17 | 260.53 | 240.08 |
Total Common Shares Outstanding | 1.58 | 1.57 | 1.48 | 1.48 |
Tangible Book Valueper Share Common Eq | 34.22 | 31.55 | 31.58 | 28.67 |
Notes Payable/ Short Term Debt | - | 92.72 | 70.75 | 80.82 |
Capital Lease Obligations | - | 0.55 | 0.17 | 0.21 |
Bal Pharma Dividend Bal Pharma Bonus Bal Pharma News Bal Pharma AGM Bal Pharma Rights Bal Pharma Splits Bal Pharma Board Meetings Bal Pharma Key Metrics Bal Pharma Shareholdings Bal Pharma Profit Loss Bal Pharma Cashflow Bal Pharma Q1 Results Bal Pharma Q2 Results Bal Pharma Q3 Results Bal Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks